Quality Care 2019: End-of-Life Use of Hormonal Agents in Patients With Prostate Cancer
How Does HIV Infection Affect Survival in Patients With Prostate Cancer?
FDA Accepts New Drug Application for Enzalutamide in Metastatic Hormone-Sensitive Prostate Cancer
FDA Safety Update on Risk of Prostate Cancer and Treatment for Parkinson’s Disease
Enzalutamide/ADT in Metastatic Hormone-Sensitive Prostate Cancer: ARCHES Trial
Should Stereotactic Body Radiation Therapy Be Standard Option in Localized Prostate Cancer?
Does Radical Prostatectomy Affect Sexual Interest and Satisfaction?
Cardiovascular Effects of Androgen-Deprivation Therapy in Prostate Cancer
Beyond the Guidelines: Investigator Perspectives on Current Clinical Issues and Ongoing Research in the Systemic Treatment of Prostate Cancer
Cases From the Community: Clinical Investigators Provide Their Perspectives on the Use of Immune Checkpoint Inhibitors in the Management of Actual Patients With Genitourinary Cancers
Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care – Prostate Cancer
Current Approaches to the Treatment of Metastatic Castration-Resistant Prostate Cancer
Duke Cancer Institute
The University of Alabama at Birmingham Comprehensive Cancer Center
University of Wisconsin Carbone Cancer Center
UC San Diego Health Moores Cancer Center
NCCN Guidelines for Patients®: Prostate Cancer
Us TOO International Prostate Cancer Education and Support Network
Prostate Conditions Education Council (PCEC)